Biopolymeric nanoparticles as drug carriers for intravenous administration

Abstract

Biopolymeric nanoparticles (BNPs) have proven to be one of the most valuable drug carriers used in nanomedicine. These submicron entities can perform several key mechanisms to adequately introduce active ingredients in the human body and release them to their specific site of action in order to achieve improved therapeutic effect. Nanocarriers may be administered intravenously in several proposed new therapies, thus, it is essential to understand all the phenomena involved in this process. This chapter attempts to describe and report the most relevant facts regarding intravenous (IV) administration of BNPs.